In addition to funding ALS research across Canada, we bring together the national ALS research community to share ideas and information and collaborate as a unified group in support of our vision to make ALS a treatable, not terminal disease.
We also support the Canadian ALS research community in contributing to international ALS initiatives that pool our resources and knowledge, enabling us to work together on solving problems that can’t be tackled alone.
By bringing the national and international ALS research communities together, the opportunities for ALS breakthroughs grow.
ALS Canada Research Forum
This annual event hosted by ALS Canada is a venue for researchers to share ideas, form new collaborations and connect with people living with ALS. The forum is attended mainly by the Canadian research community and also, people living with ALS and their family members, volunteers, donors, sponsor representatives and ALS Canada board members. 2017 Research Forum details are coming soon and will be posted here when available.
Event Sponsorships and Travel Awards
To be able to respond nimbly to new ALS research discoveries, ALS Canada sponsors ad-hoc gatherings of ALS researchers to share knowledge on timely topics related to ALS. Sponsorship requests are reviewed and assessed by ALS Canada’s Scientific and Medical Advisory Council. Recent examples of sponsored events include a bi-annual international workshop on frontotemporal dementia in ALS, the global ALS Clinical Trials Guidelines workshop and the Symposium de la Fondation André-Delambre sur la sclérose latérale amyotrophique (SLA).
We also provide travel stipends to up to 15 Canadian ALS researchers each year to present their work at the International Symposium on ALS/MND. Organized by the International Alliance of ALS/MND Associations, it is the premiere international ALS research conference in the world.
Contact us to learn more about sponsorship funds or travel awards.
National Research Network
ALS Canada is actively facilitating the development of a formalized network of researchers across the country. In previous years, The Canadian ALS Research Network (CALS) sought to bring world class clinical trials to sites across Canada. This clinical network is now being enhanced and broadened in order to better integrate preclinical research studies. Once established, the new network will reflect a true “bench to bedside” approach that bridges basic laboratory science and clinical application. More information will be available on this site as the network evolves.
ALS Disease Registry
The ALS Canada research program has also supported building the foundation of a national registry for ALS, housed in the Canadian Neuromuscular Disease Registry (CNDR). This database is designed to learn more about the clinical aspects of Canadians living with ALS and the care they receive. This tool, alongside the Canadian ALS Clinical Practice Guidelines are working towards a standard of care for people living with ALS across the country.
Clinical Practice Guidelines
Since 2014, a working group of ALS specialists has been creating a set of Canadian guidelines that will represent standards of care for people living with ALS. Once completed, the guidelines will support physicians across the country in delivering appropriate care to people living with ALS. They will also serve as a tool for clinicians and other stakeholders to advocate at local, provincial and federal levels with hospitals, lawmakers and others who can affect change to ensure the standards of care are being met. ALS Canada has supported all aspects of the evidence-based process to develop the guidelines, including convening the working group and professional literature searches.